Hara H - Search Results

1

Effects of poly(ADP-ribose) polymerase inhibitor on NMDA-induced retinal injury.

Oku H, Goto W, Okuno T, Kobayashi T, Sugiyama T, Ota T, Yoneda S, Hara H, Ikeda T. Oku H, et al. Among authors: hara h. Curr Eye Res. 2004 Dec;29(6):403-11. doi: 10.1080/02713680490517917. Curr Eye Res. 2004. PMID: 15764084

2

Brain-derived neurotrophic factor inhibits changes in soma-size of retinal ganglion cells following optic nerve axotomy in rats.

Ota T, Hara H, Miyawaki N. Ota T, et al. Among authors: hara h. J Ocul Pharmacol Ther. 2002 Jun;18(3):241-9. doi: 10.1089/108076802760116160. J Ocul Pharmacol Ther. 2002. PMID: 12099545

3

Protective effects of timolol against the neuronal damage induced by glutamate and ischemia in the rat retina.

Goto W, Ota T, Morikawa N, Otori Y, Hara H, Kawazu K, Miyawaki N, Tano Y. Goto W, et al. Among authors: hara h. Brain Res. 2002 Dec 20;958(1):10-9. doi: 10.1016/s0006-8993(02)03372-3. Brain Res. 2002. PMID: 12468025

4

Topiramate reduces excitotoxic and ischemic injury in the rat retina.

Yoneda S, Tanaka E, Goto W, Ota T, Hara H. Yoneda S, et al. Among authors: hara h. Brain Res. 2003 Mar 28;967(1-2):257-66. doi: 10.1016/s0006-8993(03)02270-4. Brain Res. 2003. PMID: 12650986

5

New fluoroprostaglandin F(2alpha) derivatives with prostanoid FP-receptor agonistic activity as potent ocular-hypotensive agents.

Nakajima T, Matsugi T, Goto W, Kageyama M, Mori N, Matsumura Y, Hara H. Nakajima T, et al. Among authors: hara h. Biol Pharm Bull. 2003 Dec;26(12):1691-5. doi: 10.1248/bpb.26.1691. Biol Pharm Bull. 2003. PMID: 14646172 Free article.

6

Bunazosin hydrochloride reduces glutamate-induced neurotoxicity in rat primary retinal cultures.

Goto W, Ichikawa M, Tanaka E, Hara H, Araie M. Goto W, et al. Among authors: hara h. Brain Res. 2004 Apr 2;1003(1-2):130-7. doi: 10.1016/j.brainres.2003.12.030. Brain Res. 2004. PMID: 15019572

7

Neuroprotective effects of beta-secretase inhibitors against rat retinal ganglion cell death.

Yamamoto R, Yoneda S, Hara H. Yamamoto R, et al. Among authors: hara h. Neurosci Lett. 2004 Nov 3;370(1):61-4. doi: 10.1016/j.neulet.2004.07.087. Neurosci Lett. 2004. PMID: 15489018

8

Comparison of the therapeutic indexes of different molecular forms of botulinum toxin type A.

Yoneda S, Shimazawa M, Kato M, Nonoyama A, Torii Y, Nishino H, Sugimoto N, Kozaki S, Hara H. Yoneda S, et al. Among authors: hara h. Eur J Pharmacol. 2005 Jan 31;508(1-3):223-9. doi: 10.1016/j.ejphar.2004.12.007. Epub 2005 Jan 11. Eur J Pharmacol. 2005. PMID: 15680275

9

Adenosine protects cultured retinal neurons against NMDA-induced cell death through A1 receptors.

Oku H, Goto W, Kobayashi T, Okuno T, Hirao M, Sugiyama T, Yoneda S, Hara H, Ikeda T. Oku H, et al. Among authors: hara h. Curr Eye Res. 2004 Dec;29(6):449-55. doi: 10.1080/02713680490522443. Curr Eye Res. 2004. PMID: 15764089

10

Vitreous fluid levels of beta-amyloid((1-42)) and tau in patients with retinal diseases.

Yoneda S, Hara H, Hirata A, Fukushima M, Inomata Y, Tanihara H. Yoneda S, et al. Among authors: hara h. Jpn J Ophthalmol. 2005 Mar-Apr;49(2):106-8. doi: 10.1007/s10384-004-0156-x. Jpn J Ophthalmol. 2005. PMID: 15838725

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,792 results

Search Page

Filters